Use of interferon and medroxyprogesterone acetate for the treatment of endometrial cancer

Oncology Reports

Volumn 3, Issue 2, 1996, Pages 351-354

  Angioli, Roberto ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Chemosensitivity; Hormone receptors; Interferon; Medroxyprogesterone acetate; Uterine cancer

Indexed keywords

INTERFERON; MEDROXYPROGESTERONE ACETATE; PROGESTERONE RECEPTOR;

ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; ENDOMETRIUM CARCINOMA; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR CELL LINE;

EID: 0030007863     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.3.2.351     Document Type: Article

References (1)

1. Pettersson F: Carcinoma of the corpus uteri. In: Annual Report on the Results of Treatment in Gynecologic Cancer. Pettersson F (ed). Panorama Press, Stockholm, Vol. 20, pp75-109, 1988.